Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Urology

• Publication date

  2007-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.UROLOGY.2007.02.064PMID 17572188
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2006

  2006cited by this paper
• Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era.

  2005cited by this paper
• Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy.

  2004cited by this paper
• The value of a second transurethral resection in evaluating patients with bladder tumours.

  2003cited by this paper
• Evaluation and follow-up strategies for superficial bladder cancer.

  2003cited by this paper
• Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer.

  2003cited by this paper
• Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study.

  2003cited by this paper
• Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses.

  2003cited by this paper
• AJCC cancer staging handbook : from the AJCC cancer staging manual

  2002cited by this paper
• Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

  2001cited by this paper
• Recurrence and progression in low grade papillary urothelial tumors.

  1999cited by this paper
• The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder

  1998cited by this paper
• Long-term survival of patients with bladder tumours: the significance of risk factors.

  1998cited by this paper
• The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

  1998cited by this paper
• Early cystectomy for clinical stage T1 transitional cell carcinoma of the bladder.

  1997cited by this paper
• Upper-tract transitional cell carcinoma.

  1997cited by this paper
• The treated natural history of high risk superficial bladder cancer: 15-year outcome.

  1997cited by this paper
• The application of a prognostic factor analysis for Ta.T1 bladder cancer in routine urological practice.

  1995cited by this paper
• Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

  1989cited by this paper

• Pathologic and survival outcomes following radical cystectomy for "progressive" and "de novo" muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status.

  2024cites this paper
• Role of plasma fibrinogen and D-dimer as prognostic biomarkers in patients with non-muscle invasive bladder cancer

  2023cites this paper
• Prognostic variations between ‘primary’ and ‘progressive’ muscle-invasive bladder cancer following radical cystectomy: a novel propensity score-based multicenter cohort study

  2023cites this paper
• Intravesical Therapy Compared to Radical Cystectomy Among Patients With Non-Muscle Invasive Bladder Cancer Requiring Additional Treatment After Induction BCG.

  2022cites this paper
• Bladder cancer with secondary muscle invasion – a prognostic dilemma

  2022cites this paper
• Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment

  2022cites this paper
• Intravesical Salvage Therapy After BCG/Regular Chemo

  2021cites this paper
• Comparison of survival outcomes between primary and secondary muscle-invasive bladder cancer: An updated meta-analysis

  2021cites this paper
• Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis

  2021influential citation
• Survival after radical cystectomy: Progressive versus De novo muscle invasive bladder cancer.

  2020cites this paper
• Oncological Outcome of Primary and Secondary Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis

  2018cites this paper
• It's all about the perspective: Removing bias when co-managing patients with high-grade T1 bladder cancer and localized prostate cancer-A competing risks analysis.

  2017cites this paper
• Primary High-Grade Non-Muscle-Invasive Bladder Cancer: High NFκB Expression in Tumor Specimens Distinguishes Patients Who are at Risk for Disease Progression

  2017cites this paper
• Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec

  2016cites this paper
• Recommendations for long-term monitoring in primary care ( all recommendations Level

  2016cites this paper
• Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.

  2016cites this paper
• Survival Comparison Between Endoscopic and Surgical Management for Patients With Upper Tract Urothelial Cancer: A Matched Propensity Score Analysis Using Surveillance, Epidemiology and End Results-Medicare Data.

  2016cites this paper
• Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer

  2015cites this paper
• Inhibition of focal adhesion kinase induces apoptosis in bladder cancer cells via Src and the phosphatidylinositol 3-kinase/Akt pathway

  2015influential citation
• Previous Bladder Cancer History in Patients with High-Risk, Non–muscle-invasive Bladder Cancer Correlates with Recurrence and Progression: Implications of Natural History

  2014cites this paper
• Tumor size and T stage correlate independently with recurrence and progression in high-risk non-muscle-invasive bladder cancer patients treated with adjuvant BCG

  2014cites this paper
• EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer.

  2014cites this paper
• Perineal urethrostomy- fast and safe access for TURB in associated long penile urethral stricture cases

  2014cites this paper
• Quality indicators in the management of bladder cancer.

  2013cites this paper
• Oncological Outcome of Primary versus Secondary Muscle-Invasive Bladder Cancer Is Comparable after Radical Cystectomy

  2013cites this paper
• Quality of care in patients with bladder cancer

  2012cites this paper
• Treatment of non-muscle-invasive bladder cancer

  2012cites this paper
• Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?

  2012cites this paper
• Indication and timing of cystectomy in high-risk bladder cancer

  2012cites this paper
• Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.

  2012cites this paper
• Non–Muscle-Invasive Bladder Cancer (Ta, T1, and CIS)

  2012cites this paper
• The Surgical Management of Invasive Bladder Cancer

  2012cites this paper
• Non-Muscle-Invasive Low- and High-Grade Neoplasia

  2012cites this paper
• Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review.

  2011cites this paper
• Challenges in the modern treatment of muscle-invasive bladder cancer.

  2011cites this paper
• Delays in diagnosis and bladder cancer mortality

  2010cites this paper
• Managing muscle-invasive bladder cancer in the elderly

  2010cites this paper
• Management of superficial bladder carcinoma: time to rethink the treatment strategies in the era of orthotopic neo-bladder.

  2010cites this paper
• The Role of Urinary Fibronectin and Telomerase in Patients with Superficial Bladder Cancer after Transurethral Resection Treated with BCG

  2010cites this paper
• Survival after cystectomy for invasive bladder cancer.

  2010cites this paper
• Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy

  2009cites this paper
• Understanding bladder cancer death

  2009cites this paper
• [Early vs delayed radical cystectomy compared in highgrade superficial bladder tumors].

  2009cites this paper
• [Disease progression in bladder cancer: which developments since 1994].

  2009cites this paper
• Patterns of care for early stage bladder cancer

  2009cites this paper
• Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer.

  2009cites this paper
• Multiple adverse histological features increase the odds of under staging T1 bladder cancer.

  2009cites this paper
• Early vs Delayed Radical Cystectomy Compared in Highgrade Superficial Bladder Tumors

  2009cites this paper